(Source:https://timesofindia.indiatimes.com/life-style/health-fitness/health-news)
The study showed that, by targeting three
distinct types of microRNA or miRNA, the new sensor can distinguish between an
acute heart attack and a reperfusion -- the restoration of blood flow, or
reperfusion injury and requires less blood than traditional diagnostic methods
to do so.
"The technology developed for this sensor
showcases the advantage of using miRNA compared to protein-based biomarkers,
the traditional diagnostic target," said Hsueh-Chia Chang from the
University of Notre Dame.
"Additionally, the portability and cost
efficiency of this device demonstrates the potential for it to improve how
heart attacks and related issues are diagnosed in clinical settings and in
developing countries," Chang added.
A patent application has been filed for the
sensor and the researchers are working with Notre Dame's IDEA Center to
potentially establish a start-up company that would manufacture the device. According to the study, published
in the journal Lab on a Chip, currently, it takes health care professionals
hours to diagnose a heart attack.
Initial results from an echocardiogram can
quickly show indications of heart disease, but to confirm a patient is having a
heart attack, a blood sample and analysis are required. Those results can take
up to eight hours.
"The current methods used to diagnose a
heart attack are not only time-intensive, but they also have to be applied
within a certain window of time to get accurate results," said lead author
Pinar Zorlutuna from the varsity.
No comments:
Post a Comment